权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Probiotics for Prevention of Early Childhood Caries

益生菌预防儿童早期龋齿

基本信息

批准号：
10892707
负责人：
Jeffrey A Banas
金额：
$ 35.47万
依托单位：
UNIVERSITY OF IOWA
依托单位国家：
美国
项目类别：
财政年份：
2023
资助国家：
美国
起止时间：
2023-09-01 至 2024-08-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/10892707
关键词：
Acceleration Acids Address Age Alkalies Animal Model Animals Anti-Inflammatory Agents Arginine Back Candida Cell Culture Techniques Child Clinical Trials Clinical Trials Design Consumption Controlled Clinical Trials Data Data Set Dedications Dental caries Development Diagnosis Effectiveness Enrollment Exhibits Future Genes Goals Grant Habits Health Health Promotion Human Incidence Intention Investigation Knowledge Longitudinal Studies Malignant Neoplasms Measures Microbe Microbiology Mind National Institute of Dental and Craniofacial Research Nutritional Oral Oral cavity Oral health Pharmacologic Substance Pharmacy facility Physiology Population Population Heterogeneity Positioning Attribute Preparation Prevention Probiotics Property Recording of previous events Reduce health disparities Research Design Research Personnel Risk Role Safety Strategic Planning Streptococcus Streptococcus mutans Streptococcus sanguis Streptococcus sobrinus Testing Time Translating Translational Research United States National Institutes of Health Urea Vulnerable Populations anticaries cohort compliance behavior design dysbiosis early childhood experience health disparity health disparity populations microbiome novel novel strategies nutrition oral microbiome safety testing

项目摘要

Project Summary In 2018, we began enrolling young children, ages 1 to 3, in a longitudinal study designed to investigate changes in the oral microbiome in advance of a caries diagnosis. We included measures of ‘traditional’ (mutans streptococci; MS) and ‘contemporary’ (Candida) cariogens but centered our main focus on non-MS low pH streptococci. This study remains on track for completion with a more robust data set than originally estimated due to lower-than-expected attrition. However, Covid-related delays have pushed back the completion of the study until after the official end of the grant period. For this competitive renewal application, we examined the current state of the data. As expected, we could not yet draw a conclusion regarding the role of non-MS low pH streptococci in caries development. However, we came upon an unexpected but exciting discovery: strains of mildly acidogenic streptococci – that we designated ‘high pH’ strains – were predominantly found in subjects who remained caries-free during their eighteen months in the study, including one caries-free subject who otherwise exhibited a cariogenic profile. This distribution of high pH strains is similar to what we previously observed with a cohort of older children. Several strains from this latter group were evaluated for desirable probiotic properties and four strains stood out. Strategic Priority #3 from the 2021-2026 NIDCR Strategic Plan is to “accelerate the translation of research . . . into practices that reduce health disparities.” This competitive renewal application is designed to do that. We propose to develop our pool of probiotic candidates by thoroughly analyzing them for their breadth of probiotic qualities, testing their safety, and developing novel means of age-appropriate and culturally sensitive delivery in preparation for a future clinical trial to reduce caries incidence in populations that historically experience caries health disparities. The specific aims of this proposal are to 1) Develop a cocktail of probiotic strains with complementary properties and safety test in cell culture and animal models; and 2) Develop the most attractive and effective means of delivery for diverse populations and children of young age. At present, there are few commercial options for probiotics specifically selected to promote oral health. Completion of the proposed aims will profoundly expand the repertoire of health-promoting oral probiotics and set the stage for testing an entirely novel approach for reducing health disparities.

项目总结